Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic Arthritis
- Conditions
- Psoriatic Arthritis
- Interventions
- Other: General evaluationOther: Dermatological evaluationOther: Rheumatological evaluationOther: para clinical dataOther: Patient reported outcomes (PROs)
- Registration Number
- NCT04325724
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
The perspective of the patient is defined by the patient reported outcomes (PROs). This is a main part of the care in psoriatic arthritis. However , PROs can be influenced by environmental parameters.
Ultrasound represents an objective instrument in the context of psoriatic rheumatism (RhPso) care because it measures inflammatory activity and structural damage at joint and periarticular level.
it is the first study to evaluate the role of inflammatory and structural ultrasound abnormalities as a cause of modification of the patient's perspective measured by PROs in patients with RhPso.
- Detailed Description
It is an interventional study. Patients will be enrolled in the rheumatology department Of Ambroise Paré Hospital in collaboration with the dermatology departments of the hospital.
All patients with psoriatic arthritis, beginner or established, or patients with psoriasis suspecting the beginning of rheumatism who will consult or are already followed in those departments and give their approval for the study will undergo
* a clinical rheumatologic assessment (number of painful or swollen joints, enthesitic pain, inflammatory spinal pain)
* an ultrasound assessment (peripheral joints, tendon and enthesitic structures and nails).
Those assessment will be made the same day of their consult in one those departments. They will be asked to complete questionnaires (PROs) on the overall assessment of the disease, pain, quality of life, tiredness, physical limitation / disability and the impact of the disease.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Patients of both genders above 18 years old
- Capable of adhering to the protocol
- Consent given
- Present one of those disease:
- RhPso (confirmed diagnosis) according to The Classification for Psoriatic arthritis criteria (CASPAR)
- Rheumatoid arthritis according to ACR/EULAR criteria (American College of Rheumatology/ European League Against Rheumatism)
- Digital osteoarthritis according to american college of rheumatology (ACR) criteria
- Cutaneous psoriasis
- Having signed a consent form
- Affiliated to a regimen of health insurance
- Patient refusing the study
- The association of two rheumatic diseases (for example: psoriatic arthritis and gout, rheumatoid arthritis and arthritis etc)
- The association of another chronic pathology likely to lead to joint manifestations (systemic diseases, bowel chronic inflammatory diseases, overload diseases, ...)
- Patient under trusteeship or protection of vulnerable adults
- Pregnant or nursing women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Skin psoriasis patients without any articular symptoms Rheumatological evaluation - Confirmed psoriatic arthritis patients Rheumatological evaluation Every patients with psoriatic arthritis followed in rheumatologic department Beginner psoriatic arthritis patients para clinical data Every patients consulting in dermatologic or rheumatologic department for a skin psoriasis with clinical symptoms which may lead to the suspicion of psoriatic arthritis Beginner psoriatic arthritis patients Dermatological evaluation Every patients consulting in dermatologic or rheumatologic department for a skin psoriasis with clinical symptoms which may lead to the suspicion of psoriatic arthritis Beginner psoriatic arthritis patients Rheumatological evaluation Every patients consulting in dermatologic or rheumatologic department for a skin psoriasis with clinical symptoms which may lead to the suspicion of psoriatic arthritis Beginner psoriatic arthritis patients Patient reported outcomes (PROs) Every patients consulting in dermatologic or rheumatologic department for a skin psoriasis with clinical symptoms which may lead to the suspicion of psoriatic arthritis Confirmed psoriatic arthritis patients Dermatological evaluation Every patients with psoriatic arthritis followed in rheumatologic department Confirmed psoriatic arthritis patients para clinical data Every patients with psoriatic arthritis followed in rheumatologic department Rheumatoid arthritis or Digital osteoarthritis patients para clinical data Followed in rheumatologic department Rheumatoid arthritis or Digital osteoarthritis patients Patient reported outcomes (PROs) Followed in rheumatologic department Skin psoriasis patients without any articular symptoms General evaluation - Beginner psoriatic arthritis patients General evaluation Every patients consulting in dermatologic or rheumatologic department for a skin psoriasis with clinical symptoms which may lead to the suspicion of psoriatic arthritis Confirmed psoriatic arthritis patients General evaluation Every patients with psoriatic arthritis followed in rheumatologic department Rheumatoid arthritis or Digital osteoarthritis patients General evaluation Followed in rheumatologic department Skin psoriasis patients without any articular symptoms Patient reported outcomes (PROs) - Confirmed psoriatic arthritis patients Patient reported outcomes (PROs) Every patients with psoriatic arthritis followed in rheumatologic department Rheumatoid arthritis or Digital osteoarthritis patients Rheumatological evaluation Followed in rheumatologic department Skin psoriasis patients without any articular symptoms Dermatological evaluation - Skin psoriasis patients without any articular symptoms para clinical data -
- Primary Outcome Measures
Name Time Method Evaluation of patient global assessment (PGA) in patients with Psoriatic Arthritis 1 day The study of patient global assessment will permit to understand the impact of inflammation and external structural damage measured by ultrasound in patients with psoriatic arthritis (newly diagnosed or with confirmed diagnosis).
At enrollment visit (only visit) of patient PGA will be assessed with a digital scale from 0 to 10
- Secondary Outcome Measures
Name Time Method Evaluation of the impact of inflammation and external structural damage measured by ultrasound 1 day Compare the results( prevalence of ultrasound irregularity, PROs, and factor which explain PROs) to people who suffer from psoriatic, without damage, without sign of joints damages or rheumatoid arthritis (RA) or digital osteoarthritis.
Ultrasound damages: Synovitis, tenosynovitis, enthesitis, dactylitis, erosions, periosteal appositions ( enthesophytes, osteophyte and bony cortical irregularity) will be defined according to established by outcome measures in rheumatology (OMERACT) definitions and rating according to scores established by OMERACT